IMUC

ImmunoCellular Therapeutics, Ltd.
IMUC

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

IMUC was delisted on the 16th of October, 2018.

Back to rankings

3 hedge funds and large institutions have $5K invested in ImmunoCellular Therapeutics, Ltd. in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
3
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.44K

Top Sellers

1
-$254K
2
-$60K
3
-$15K
4
VF
Virtu Financial
New York
-$15K
5
TSS
Two Sigma Securities
New York
-$13K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$5K
2
–
3
–
4
–
5
–
6
–
7
–
8
–
9
–
10
–
11
–
12
–
13
–